Roche scientists developed novel bead technology to automate mass spectrometry, increasing clinician and patient access to this sensitive diagnostic technology.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.